The Indian Academy of Pediatrics (IAP) recommends the Meningococcal Conjugate Vaccine (MCV4) to protect against Meninococcal serogroups A, C, Y, and W-135. Usually advised for children at risk, travelers or during outbreaks, it can be safely administered to children as part of immunization. The vaccine protects against fatal meningitis and septicemia caused by Neisseria meningitidis.